D. Manfreda

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

Michael Gnant, Georg Pfeiler, Peter Dubsky et al. · The Lancet · 2015 · 560 citations

Medicine, Oncology, Pharmacology +13

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer

Michael Gnant, Florian Fitzal, Gabriel Rinnerthaler et al. · New England Journal of Medicine · 2021 · 161 citations · Full text

Medicine, Oncology, Pharmacology +17

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 122 citations

Medicine, Gynecology, Oncology +13

Abstract GS3-01: A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine therapy – results from 3,484 postmenopausal women in the ABCSG-16 trial

Michael Gnant, G. Steger, Richard Greil et al. · Cancer Research · 2018 · 37 citations

Medicine, Oncology, Pharmacotherapy +17

Randomized Trial of Low-Dose Chemotherapy Added to Tamoxifen in Patients With Receptor-Positive and Lymph Node–Positive Breast Cancer

R. Jakesz, H. Hausmaninger, K. Haider et al. · Journal of Clinical Oncology · 1999 · 34 citations

Medicine, Oncology, Pharmacotherapy +15